279
staff
Michelle Longmire
Dr. Michelle Longmire is mission-driven to accelerate the development of new therapies for diseas
e as the founder and Chief Executive Officer of Medable. A Stanford-trained physician-scientist, Dr.
+ Read More
staff
Debi Brooks
Deborah W. Brooks is Chief Executive Officer (CEO) and Co-Founder of The Michael J. Fox Foundatio
n for Parkinson's Research (MJFF). Ms. Brooks launched MJFF with Michael J. Fox in 2000 and served as founding CEO until 2007.
+ Read More
staff
Christopher Austin
Christopher Austin, MD, is a CEO-partner at Flagship Pioneering in Cambridge, MA, and CEO of Vesa
lius Therapeutics, one of Flagship’s franchise companies that is commercializing a platform to systematically develop treatments for common diseases.
+ Read More
report
Demographic Reporting and Mix in Clinical Trials
Clinical trial enrollment can vary based on demographics. Cancer drug trials, for example, have bee
n shown to skew disproportionately toward young, White, male participants.
+ Read More
report
Innovative Finance Models for Global Early Warning Systems for Pandemics
Despite lessons learned from COVID-19 and other outbreaks, the world remains ill-prepared for the n
ext pandemic.
+ Read More
report
Best Practices of Sovereign Wealth Funds: The Case for The Philippines
Many nations create sovereign wealth funds (SWFs) to invest surplus assets in a diversified portfol
io approach to achieve national policy goals, hedge against economic risk, and benefit successive generations.
+ Read More
report
Our Shared Responsibility: Technologies Accelerating the Path to Green Financing
In a private roundtable at the 2022 Singapore Fintech Festival, leading technologists, chief sustai
nability officers, large investors, and financial regulators gathered for off-the-record dis
+ Read More
report
Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard
Since early in the COVID-19 pandemic, FasterCures has been committed to capturing lessons learned a
nd opportunities to improve the biomedical research ecosystem.
+ Read More
report
Corporate Philanthropy: Emerging Strategies for Lasting Impact
Corporate philanthropy is in transition. External trends and heightened stakeholder expectations ha
ve placed new pressures on the corporate sector.
+ Read More
report
Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program
The Kissick Family Foundation, with guidance from MI Philanthropy’s Science and Health team, is rel
easing its first Request for Proposals (RFP) to fund research that accelerates basic and fundamental discoveries for sporadic FTD.
+ Read More
report
Frontotemporal Dementia: A Giving Smarter Guide
Frontotemporal dementia (FTD) refers to a family of neurodegenerative conditions that cause changes
in behavior, mood, executive function, language, memory, and motor function.
+ Read More
panel